How does BEYOND BiHiVE work?
BEYOND BiHiVE can be seen as part of the BiHiVE2 study. It also focuses on inflammatory markers, and will target the markers with the most potential for a bedside diagnostic test.
Once the findings of BEYOND BiHiVE are validated, researchers will move on to developing the bedside algorithm, which will provide a point-of-care diagnosis for HIE.
INFANT has identified predictive protemoic and metabolomic markers for HIE.